Paul Telfer, MA, DM, BM, BCh, FRCP, FRCPath - Decoding the Future: Bringing Gene Therapy Into Prime Time for Patients With Sickle Cell Disease episode artwork

EPISODE · Jul 4, 2024 · 13 MIN

Paul Telfer, MA, DM, BM, BCh, FRCP, FRCPath - Decoding the Future: Bringing Gene Therapy Into Prime Time for Patients With Sickle Cell Disease

from CME in Minutes: Education in Oncology & Hematology · host Answers in CME

Please visit answersincme.com/HRY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology discusses the use of gene therapy for the treatment of sickle cell disease (SCD). Upon completion of this activity, participants should be better able to: Identify the rationale for the use of gene therapy in sickle cell disease; Review the clinical significance of the latest trial data for gene therapy in sickle cell disease; and Outline considerations to optimize the use of gene therapy in patients with sickle cell disease.

Episode metadata supplied by the publisher feed · Published Jul 4, 2024

Embed this episode

NOW PLAYING

Paul Telfer, MA, DM, BM, BCh, FRCP, FRCPath - Decoding the Future: Bringing Gene Therapy Into Prime Time for Patients With Sickle Cell Disease

0:00 13:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CME in Minutes: Education in Oncology & Hematology?

This episode is 13 minutes long.

When was this CME in Minutes: Education in Oncology & Hematology episode published?

This episode was published on July 4, 2024.

Can I download this CME in Minutes: Education in Oncology & Hematology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!